Medicare Reimbursements and Shortages of Sterile Injectable Pharmaceuticals
NBER Working Paper No. 17987
---- Acknowledgements -----
I thank Ernst Berndt, John Beshears, Tim Bresnahan, Jeremy Bulow, Rob Chess, Jeffrey Clemens, Rena Conti, Liran Einav, Sherry Glied, Joshua Gottlieb, Rick Hornbeck, Mireille Jacobsen, Michael Link, Steve Mayer, Ted Okon, Michael Ostrovsky, Paul Oyer, Mar Reguant, Peter Reiss, Fiona Scott Morton, Robert Wilson, and Stefanos Zenios for comments. Special thanks to Lanier Benkard and Daniel Kessler who early on suggested theoretical mechanisms that are central to this paper. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.